Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling

Purpose: Our understanding of adrenocortical carcinoma (ACC) has improved considerably, yet many unanswered questions remain. For instance, can molecular subtypes of ACC be identified? If so, what is their underlying pathogenetic basis and do they possess clinical significance? Experimental Design: We did a whole genome gene expression study of a large cohort of adrenocortical tissues annotated with clinicopathologic data. Using Affymetrix Human Genome U133 Plus 2.0 oligonucleotide arrays, transcriptional profiles were generated for 10 normal adrenal cortices (NC), 22 adrenocortical adenomas (ACA), and 33 ACCs. Results: The overall classification of adrenocortical tumors was recapitulated using principal component analysis of the entire data set. The NC and ACA cohorts showed little intragroup variation, whereas the ACC cohort revealed much greater variation in gene expression. A robust list of 2,875 differentially expressed genes in ACC compared with both NC and ACA was generated and used in functional enrichment analysis to find pathways and attributes of biological significance. Cluster analysis of the ACCs revealed two subtypes that reflected tumor proliferation, as measured by mitotic counts and cell cycle genes. Kaplan-Meier analysis of these ACC clusters showed a significant difference in survival (P < 0.020). Multivariate Cox modeling using stage, mitotic rate, and gene expression data as measured by the first principal component for ACC samples showed that gene expression data contains significant independent prognostic information (P < 0.017). Conclusions: This study lays the foundation for the molecular classification and prognostication of adrenocortical tumors and also provides a rich source of potential diagnostic and prognostic markers.

[1]  A. Hoeflich,et al.  Role of the Insulin-like Growth Factor System in Adrenocortical Growth Control and Carcinogenesis , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[3]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[4]  Christine Gicquel,et al.  Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors. , 2004, European journal of endocrinology.

[5]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[6]  Alok J. Saldanha,et al.  Java Treeview - extensible visualization of microarray data , 2004, Bioinform..

[7]  D. Marsh,et al.  Comparative genomic hybridization analysis of adrenocortical tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[8]  T. Barrette,et al.  Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.

[9]  J. Bourhis,et al.  Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer , 2007, Nature Clinical Practice Oncology.

[10]  P. Heikkilä,et al.  Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  L. Medeiros,et al.  Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma , 1989, The American journal of surgical pathology.

[12]  Takashi Suzuki,et al.  Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma , 2006, Endocrine pathology.

[13]  T. Abe,et al.  Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. , 2008, Endocrine journal.

[14]  E. Speel,et al.  Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. , 1999, The American journal of pathology.

[15]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[16]  Sharon L R Kardia,et al.  Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. , 2003, The American journal of pathology.

[17]  T. Giordano.  Molecular pathology of adrenal cortical tumors: Separating adenomas from carcinomas , 2006, Endocrine pathology.

[18]  J. Bertherat,et al.  Insights into the Molecular Biology of Adrenocortical Tumors , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[19]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Bertherat,et al.  Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectives , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[22]  Stefano Monti,et al.  Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Papotti,et al.  Adjuvant mitotane treatment for adrenocortical carcinoma. , 2007, The New England journal of medicine.

[24]  D. Bartsch,et al.  Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. , 2006, European journal of endocrinology.

[25]  A. Hartmann,et al.  Spontaneous rupture of a benign giant adrenal adenoma , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[26]  Takashi Suzuki,et al.  Discerning malignancy in resected adrenocortical neoplasms , 2001, Endocrine pathology.

[27]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[28]  G Rennert,et al.  Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. , 2001, The American journal of pathology.

[29]  Ximing J. Yang,et al.  Molecular subclassification of kidney tumors and the discovery of new diagnostic markers , 2003, Oncogene.

[30]  F. Berger,et al.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. , 2005, The Journal of clinical endocrinology and metabolism.

[31]  C. Gicquel,et al.  Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. , 1999, Journal of molecular endocrinology.

[32]  D. Schteingart.  Prognostic Parameters of Metastatic Adrenocortical Carcinoma , 2008 .

[33]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[34]  T. Giordano,et al.  Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  E. Baudin,et al.  Prognostic parameters of metastatic adrenocortical carcinoma. , 2007, The Journal of clinical endocrinology and metabolism.

[36]  J. Bertherat,et al.  Adrenocortical cancer: pathophysiology and clinical management. , 2007, Endocrine-related cancer.

[37]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[39]  David E. Misek,et al.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis , 2005, Oncogene.

[40]  P. Devos,et al.  Weiss System Revisited: A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors , 2002, The American journal of surgical pathology.

[41]  L. Weiss.  Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors , 1984, The American journal of surgical pathology.

[42]  Paul G Gauger,et al.  Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. , 2003, The American journal of pathology.

[43]  D. Yee,et al.  Disrupting insulin-like growth factor signaling as a potential cancer therapy , 2007, Molecular Cancer Therapeutics.

[44]  E. Lalli,et al.  Gene expression profiling of childhood adrenocortical tumors. , 2007, Cancer research.

[45]  C. Cordon-Cardo,et al.  Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  C. Larsson,et al.  Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. , 1996, Cancer research.

[47]  Joakim Lundeberg,et al.  Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. , 2005, Surgery.

[48]  P. Lichter,et al.  Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high‐level amplifications , 2000, Genes, chromosomes & cancer.

[49]  M. Salvatore,et al.  Andrenocortical Carcinomas: Twelve-year Prospective Experience , 2004, World Journal of Surgery.

[50]  Jeffrey M Trent,et al.  Adrenocortical carcinoma survival rates correlated to genomic copy number variants , 2008, Molecular Cancer Therapeutics.

[51]  Z. Szallasi,et al.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.

[52]  J. Bertherat,et al.  Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. , 2005, European journal of endocrinology.